In 2003, the German Cancer Society (Deutsche Krebsgesellschaft, DKG) launched a certification program aimed at improving the quality of cancer care.

First-line treatment of patients with recurrent, metastatic prostate cancer involves hormone therapy with or without additional systemic therapies.

MicroRNA-155 (miR-155) may function as a diagnostic biomarker of breast cancer (BC).

To develop a CT texture-based model able to predict epidermal growth factor receptor (EGFR)-mutated, anaplastic lymphoma kinase

Prior studies suggest that nationally endorsed quality measures for prostate cancer care are not linked closely with outcomes. Using a prospective...

To report our experience and lessons learned as high-volume center of robotic surgery managing patients with prostate cancer since the beginning of...

Early diagnosis has been proved to improve survival rate of lung cancer patients

Genomic profiling of tumors has become the mainstay for diagnosis, treatment monitoring and a guide to precision medicine